| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/05/2013 | CN103127059A Oral administration preparation composed of bilobalide B derivative and preparation method thereof |
| 06/05/2013 | CN103127053A Medical application of 6-[2-(dimethylamino)ethoxy]flavone |
| 06/05/2013 | CN103127045A Composition containing gamma-aminobutyric acid and lycopene and preparation method thereof |
| 06/05/2013 | CN103127035A Amlodipine besylate membrane preparation |
| 06/05/2013 | CN103127030A Propylene glycol alginate sodium sulfate enteric capsule and preparation method thereof |
| 06/05/2013 | CN103127027A Polysaccharide sulphate dropping pill |
| 06/05/2013 | CN103127024A Stable disodium adenosine triphosphate tablet |
| 06/05/2013 | CN103127018A Levamlodipine besylate tablet and preparation method thereof |
| 06/05/2013 | CN103127016A Bisoprolol fumarate tablet composition and preparation method thereof |
| 06/05/2013 | CN103127013A Polysaccharide sulphate lipidosome tablet |
| 06/05/2013 | CN103127010A Stable candesartan cilexetil tablet combination |
| 06/05/2013 | CN103127009A Carthamin yellow sublingual tablet and preparation method and application thereof |
| 06/05/2013 | CN103127008A Improved formula of vinpocetine oral preparation and application |
| 06/05/2013 | CN103127004A Propylene glycol alginate sodium sulfate controlled-release granule and preparation method thereof |
| 06/05/2013 | CN103127000A Isosorbide mononitrate chronopharmacological sustained release pellet drug delivery system and its preparation method |
| 06/05/2013 | CN103126994A Solid medicine composition containing dronedarone |
| 06/05/2013 | CN103126986A Emulsion for clevidipine butyrate intravenous injection and preparation method thereof |
| 06/05/2013 | CN103126979A Luteolin solution composition |
| 06/05/2013 | CN103126415A Neck guard and blood pressure reducing drug pillow |
| 06/05/2013 | CN103126252A Multi-function portable box |
| 06/05/2013 | CN103125946A Lutein nanoparticle and its preparation method |
| 06/05/2013 | CN103125928A Preparation method of gastrodia elata essence |
| 06/05/2013 | CN102657828B Pharmaceutical composition for treating chronic heart failure |
| 06/05/2013 | CN102634432B Desert cistanche and black rice health maintenance wine and production method thereof |
| 06/05/2013 | CN102559472B Health-care rice vinegar and preparation process thereof |
| 06/05/2013 | CN102552700B 一种脉络宁组合物 One kind of composition Mailuoning |
| 06/05/2013 | CN102430094B Traditional Chinese medicine decoction for treating angina pectoris |
| 06/05/2013 | CN102389470B Traditional Chinese medicinal composition for promoting blood circulation and removing obstructions in channels |
| 06/05/2013 | CN102370809B Self-heated traditional Chinese medicine (TCM) emplastrum for preventing and curing hypertension |
| 06/05/2013 | CN102366451B Self-heated traditional Chinese medicine (TCM) emplastrum for improving stroke sequelae |
| 06/05/2013 | CN102357220B Traditional Chinese medicine composition for treating early-stage lower limb thrombotic deep phlebitis |
| 06/05/2013 | CN102335176B Brand-new oral solid medicinal composition and preparation method thereof |
| 06/05/2013 | CN102335129B Edaravone medicinal composition for injection and preparation method thereof |
| 06/05/2013 | CN102327566B Traditional Chinese medicine preparation for curing ventricular extrasystole |
| 06/05/2013 | CN102296101B Method for preparing micro capsulate embedded antihypertensive peptide |
| 06/05/2013 | CN102247400B Blood lipid-reducing effect of panax japonicus polysaccharide |
| 06/05/2013 | CN102247391B Application of panax japonicus saponin V to reduction of blood fat |
| 06/05/2013 | CN102228446B Alprostadil lipid nanosphere freeze-drying injection and preparation method thereof |
| 06/05/2013 | CN102100704B Application of probiotic strain GM-080 in preparing composition for treating carditis and heart apoptosis |
| 06/05/2013 | CN102088972B Pharmaceutical compositions containing imidazole-5-carboxylic acid derivatives and preparation method and use thereof |
| 06/05/2013 | CN102050787B Guanidine derivatives and preparation, medicinal composition and application in preparation of medicaments for treating metabolic syndromes |
| 06/05/2013 | CN102018685B Terazosin pellicle and preparation method thereof |
| 06/05/2013 | CN102000109B Pharmaceutical preparation using hydrogen as therapeutic substance and preparation method thereof |
| 06/05/2013 | CN101991612B Preparation method of haematococcus pluvialis extracts |
| 06/05/2013 | CN101906104B 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 06/05/2013 | CN101802174B Cell growth method and pharmaceutical preparation for tissue repair and regeneration |
| 06/05/2013 | CN101780097B Application of DGPP (diacylglycerol pyrophosphate) in preparation of medicines for treating ischemic heart disease |
| 06/05/2013 | CN101744999B Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof |
| 06/05/2013 | CN101744997B Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof |
| 06/05/2013 | CN101744986B Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof |
| 06/05/2013 | CN101704799B Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
| 06/05/2013 | CN101679363B Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same |
| 06/05/2013 | CN101678030B Use of riboflavin in the treatment of hypertension |
| 06/05/2013 | CN101622005B New use of nitrites and nitrates and compositions containing these |
| 06/05/2013 | CN101583601B Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2 |
| 06/05/2013 | CN101574379B Flavone hippophaes self-emulsifying formulation and preparation method thereof |
| 06/05/2013 | CN101460624B Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same |
| 06/05/2013 | CN101336920B Stable medicine combination |
| 06/05/2013 | CN101141964B Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 06/04/2013 | US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455017 Active substance for improving hyperlipidemia and hypercholesterolemia |
| 06/04/2013 | US8454994 Stable pharmaceutical composition and methods of using same |
| 06/04/2013 | CA2512820C Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 05/30/2013 | WO2013078413A1 Modulators of lipid storage |
| 05/30/2013 | WO2013077709A1 Pharmaceutical composition for preventing or treating restenosis comprising epidithiodioxopiperazine compounds or derivatives thereof, or pharmaceutically acceptable salts thereof |
| 05/30/2013 | WO2013077228A1 Impdh inhibitor having microrna as active component |
| 05/30/2013 | WO2013076331A1 Phosphorylation on the thr-248 and/or thr-250 residues of transcription factor e2f4 as a therapeutic target in pathological processes associated with somatic polyploidy |
| 05/30/2013 | WO2013076168A1 Method for producing substituted 5-fluoro-1h-pyrazolopyridines |
| 05/30/2013 | WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/30/2013 | WO2013075391A1 Electromagnetic therapeutic apparatus and supporting physiotherapy liquid thereof |
| 05/30/2013 | WO2013056245A3 Stearate compounds |
| 05/30/2013 | US20130137118 Integrin heterodimer and a subunit thereof |
| 05/30/2013 | US20130136775 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
| 05/30/2013 | CA2856706A1 Method for producing substituted 5-fluoro-1h-pyrazolopyridines |
| 05/30/2013 | CA2854569A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/29/2013 | EP2597095A1 Fused heterocyclic compound and application thereof |
| 05/29/2013 | EP2597089A1 Tricyclic heterocyclic compounds |
| 05/29/2013 | EP2597083A2 Selective hydroxamate based MMP inhibitors |
| 05/29/2013 | EP2596800A1 Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia |
| 05/29/2013 | EP2596785A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 05/29/2013 | EP2596020A2 Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy |
| 05/29/2013 | EP2595977A1 Process for preparing benzofuran derivatives substituted at position 5 |
| 05/29/2013 | EP2595969A1 Substituted 3-phenyl-1,2,4-oxadiazole compounds |
| 05/29/2013 | EP2595952A1 Agonists of gpr40 |
| 05/29/2013 | EP2595633A2 Methods of intravenous administration of glyburide and other drugs |
| 05/29/2013 | EP2595630A1 Use of a2b adenosine receptor antagonists for treating pulmonary hypertension |
| 05/29/2013 | EP2595615A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 05/29/2013 | CN1671643B Bipolar trans carotenoid salts and their uses |
| 05/29/2013 | CN103124727A Substituted 3-phenyl-1,2,4-oxadiazole compounds |
| 05/29/2013 | CN103122293A Onion root hair wine and brewing process thereof |
| 05/29/2013 | CN103122031A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 05/29/2013 | CN103122022A Angiotensin converting enzyme inhibitory peptide derived from bitter almond protein and preparation method thereof |
| 05/29/2013 | CN103122001A Polo-like kinase inhibitors |
| 05/29/2013 | CN103121998A Vinpocetine compound and drug composition thereof |
| 05/29/2013 | CN103121986A Crystal form E of 7-hydroxyisoflavone and preparation method thereof, and pharmaceutical composition and application thereof |
| 05/29/2013 | CN103121985A Beta-adrenergic blocking agent based on soy isoflavone derivatives and preparation method and purpose thereof |
| 05/29/2013 | CN103121973A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103120798A Preparation method and application of phospholipid complex with anti-oxidative stress |
| 05/29/2013 | CN103120791A Traditional Chinese medicine composition for treating vital myocarditis and preparation method thereof |